Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance

Author: Nilsson Peter M.   Hedblad Bo   Donaldson Jill   Berglund Göran  

Publisher: Informa Healthcare

ISSN: 0803-7051

Source: Blood Pressure, Vol.16, Iss.2, 2007-01, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content